BLS-0602

N/A

Report date: 2023/02/04 20:01:26

Base Information

Drug NameBLS-0602
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolyamine uptake inhibitorsDopamine transporter antagonists
TargetsDopamine transporter
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBoston Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoston Life Sciences
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A